Search research articles
Contact Us
Filters
Showing results (181-190 of 266) with videos related to
Page
of 27
Sort By:
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews
|
February 3, 2023
The Impact of Sex on the Outcomes of Prosthetic Joint Infection Treatment with Debridement, Antibiotics and Implant Retention: A Systematic Review and Individual Patient Data Meta-analysis
Annabelle L Choong, Cade Shadbolt, Emma Choong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 25, 2021
A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia
Brendan L Harney, Bradley Whitton, Emma Paige, et al.
The Lancet. HIV
|
April 13, 2018
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial
Thomas A Rasmussen, James H McMahon, J Judy Chang, et al.
The International Journal on Drug Policy
|
June 28, 2015
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C
Maryam Alavi, Tim Spelman, Gail V Matthews, et al.
Pharmacoeconomics
|
March 13, 2026
Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty
An Tran-Duy, Sarah Asbury, Tim Spelman, et al.
BMJ Open
|
July 30, 2021
Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trial
Solomon Abrha, Julia K Christenson, John McEwen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 30, 2025
Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)-Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection
Jennifer Audsley, Anchalee Avihingsanon, Xin Li, et al.
AIDS (London, England)
|
March 17, 2017
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy
Talia M Mota, Thomas A Rasmussen, Ajantha Rhodes, et al.
Multiple Sclerosis and Related Disorders
|
February 6, 2023
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity
Tim Spelman, Dana Horakova, Serkan Ozakbas, et al.
Multiple Sclerosis and Related Disorders
|
November 29, 2017
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 266) with videos related to
Sort By:
Page
of 27
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews
|
February 3, 2023
The Impact of Sex on the Outcomes of Prosthetic Joint Infection Treatment with Debridement, Antibiotics and Implant Retention: A Systematic Review and Individual Patient Data Meta-analysis
Annabelle L Choong, Cade Shadbolt, Emma Choong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 25, 2021
A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia
Brendan L Harney, Bradley Whitton, Emma Paige, et al.
The Lancet. HIV
|
April 13, 2018
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial
Thomas A Rasmussen, James H McMahon, J Judy Chang, et al.
The International Journal on Drug Policy
|
June 28, 2015
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C
Maryam Alavi, Tim Spelman, Gail V Matthews, et al.
Pharmacoeconomics
|
March 13, 2026
Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty
An Tran-Duy, Sarah Asbury, Tim Spelman, et al.
BMJ Open
|
July 30, 2021
Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trial
Solomon Abrha, Julia K Christenson, John McEwen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 30, 2025
Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)-Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection
Jennifer Audsley, Anchalee Avihingsanon, Xin Li, et al.
AIDS (London, England)
|
March 17, 2017
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy
Talia M Mota, Thomas A Rasmussen, Ajantha Rhodes, et al.
Multiple Sclerosis and Related Disorders
|
February 6, 2023
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity
Tim Spelman, Dana Horakova, Serkan Ozakbas, et al.
Multiple Sclerosis and Related Disorders
|
November 29, 2017
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Page
of 27